bpc 157 derived from gastric juice peptide Frontiers What is BPC-157? Dosing &
Description
Selected Clinical Trial Activity 5-Amino-1MQ is a research-grade compound that has been studied in laboratory settings but has not undergone full clinical development
Enhances recovery and joint repair
Common effects: Injection-site reactions (mild redness, slight discomfort) most common Transient headaches (resolved without intervention) Mild fatigue in some subjects (usually early in treatment) No serious adverse events reported Laboratory changes: No significant changes in blood glucose or insulin levels No effects on liver enzymes or kidney function No changes in IGF-1 levels (confirming the absence of a GH rise) No clinically significant changes in other laboratory parameters Phase 2 trials (overweight/obese subjects): Efficacy trials in overweight and obese populations confirmed the favorable safety profile
3 days after the 1st jab, I experienced heart palpitations which led me to consult with a cardiologist
